NUCRYST Pharmaceuticals (Nasdaq: NCST) 94% HIGHER; Announced that the FDA has granted 510(k) clearance for a prescription topical cream containing ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE